Anti-tumor efficacy in SIOPEL 6: A multi-centre open label randomised phase III trial of the efficacy of sodium thiosulphate (STS) in reducing ototoxicity in patients receiving cisplatin (Cis) monotherapy for standard risk hepatoblastoma (SR-HB).

Pénélope Brock ,Bruce Morland,Margaret Childs,Jane Skeen,Edward A Neuwelt,Piotr Czauderna,Michael Capra,Kaukab Rajput,Rudolf Maibach,Milind Ronghe,Eiso Hiyama,Liane Lockwood,Véronique Laithier ,Michael J Sullivan ,Derek Roebuck ,María Elena Mateos ,Patrizia Dall’igna ,Monique Fabrè ,Arun Rangaswami ,Bénédicte Brichard

doi:10.1200/jco.2015.33.15_suppl.10039

Anti-tumor efficacy in SIOPEL 6: A multi-centre open label randomised phase III trial of the efficacy of sodium thiosulphate (STS) in reducing ototoxicity in patients receiving cisplatin (Cis) monotherapy for standard risk hepatoblastoma (SR-HB).

Pénélope Brock , Bruce Morland + Show 18 more

https://doi.org/10.1200/jco.2015.33.15_suppl.10039

Copy DOI

Journal: Journal of Clinical Oncology	Publication Date: May 20, 2015
Citations: 1

Affiliation: University College London, Great Ormond Street Hospital, Birmingham Children's Hospital, Starship Children's Health, Oregon Health & Science University, Gdańsk Medical University, Children's Health Ireland at Crumlin, International Breast Cancer Study Group, Royal Hospital for Children, Hiroshima University, Royal Children's Hospital, Centre Hospitalier Universitaire de Besançon, Hospital Universitario Reina Sofía, University of Padua, Institut Gustave Roussy, Palo Alto University, Cliniques Universitaires Saint-Luc

#Standard Risk Hepatoblastoma #Ototoxicity In Patients + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

10039 Background: SR-HB is defined as tumor extension limited to PRETEXT I, II or III, no portal, hepatic veins, or intra-abdominal extra-hepatic disease, AFP > 100ng/ml and no metastases. Cis can ...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.